Potential Role of microRNA-21 in the Diagnosis of Gastric Cancer: A Meta-Analysis

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Zeng, Zongyue ^a   Wang, Jiangen ^a   Zhao, Liuyang ^a   Hu, Ping ^a   Zhang, Hailong ^a   Tang, Xi ^a   He, Dali ^a   Tang, Shifu ^a   Zeng, Zhaofang ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 21;

ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; GENE FUNCTION; HISTOPATHOLOGY; HUMAN; META ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; SYSTEMATIC REVIEW; TASK PERFORMANCE;

HUMANS; MICRORNAS; STOMACH NEOPLASMS;

EID: 84883333652     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073278     Document Type: Article

References (49)

1. Society AAC (2011) Global Cancer Facts & Figures 2nd Edition. American Cancer Society.
2. Meng F, Henson R, Lang M, Wehbe H, Maheshwari S, et al. (2006) Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines. Gastroenterology 130: 2113-2129.
3. Garcia M, Jemal A (2011) Global Cancer Facts and Figures 2011. Atlanta, GA: American Cancer Society.
4. Tan YK, Fielding JW, (2006) Early diagnosis of early gastric cancer. European journal of gastroenterology & hepatology 18: 821-829.
5. Flynt AS, Lai EC, (2008) Biological principles of microRNA-mediated regulation: shared themes amid diversity. Nat Rev Genet 9: 831-842.
6. Carthew RW, Sontheimer EJ, (2009) Origins and Mechanisms of miRNAs and siRNAs. Cell 136: 642-655.
7. Lewis BP, Burge CB, Bartel DP, (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
8. Krol J, Loedige I, Filipowicz W, (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11: 597-610.
9. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nature reviews Cancer 6: 857-866.
10. Chen X, Ba Y, Ma L, Cai X, Yin Y, et al. (2008) Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18: 997-1006.
11. Filipowicz W, Bhattacharyya SN, Sonenberg N, (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9: 102-114.
12. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America 105: 10513-10518.
13. Zamore PD, Haley B, (2005) Ribo-gnome: the big world of small RNAs. Science 309: 1519-1524.
14. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, et al. (2004) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proceedings of the National Academy of Sciences of the United States of America 101: 2999-3004.
15. Jiang Z, Guo J, Xiao B, Miao Y, Huang R, et al. (2010) Increased expression of miR-421 in human gastric carcinoma and its clinical association. J Gastroenterol 45: 17-23.
16. Zhang Y, Guo J, Li D, Xiao B, Miao Y, et al. (2010) Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance. Med Oncol 27: 685-689.
17. Zhang B, Pan X, Cobb GP, Anderson TA, (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302: 1-12.
18. Cui L, Zhang X, Ye G, Zheng T, Song H, et al. (2013) Gastric juice MicroRNAs as potential biomarkers for the screening of gastric cancer. Cancer 119: 1618-1626.
19. Yamanaka Y, Tagawa H, Takahashi N, Watanabe A, Guo YM, et al. (2009) Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. Blood 114: 3265-3275.
20. Chan S-H, Wu C-W, Li AF-Y, Chi C-W, Lin W-C, (2008) miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer research 28: 907-911.
21. Zhang Z, Li Z, Gao C, Chen P, Chen J, et al. (2008) miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Laboratory Investigation 88: 1358-1366.
22. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J, (2003) The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Medical Research Methodology 3: 25.
23. Mitchell AJ, Vaze A, Rao S, (2009) Clinical diagnosis of depression in primary care: a meta-analysis. The Lancet 374: 609-619.
24. Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, et al. (2005) Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. Journal of clinical epidemiology 58: 982-990.
25. Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JA, (2007) A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 8: 239-251.
26. Harbord RM, Whiting P, Sterne J, Egger M, Deeks JJ, et al. (2008) An empirical comparison of methods for meta-analysis of diagnostic accuracy showed hierarchical models are necessary. Journal of clinical epidemiology 61: 1095-1103.
27. Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM, (2008) Systematic reviews of diagnostic test accuracy. Annals of internal medicine 149: 889-897.
28. Higgins J, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. Bmj 327: 557-560.
29. Dinnes J, Deeks J, Kirby J, Roderick P, (2005) A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy. Health Technology Assessment 9: 1-113.
30. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A, (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC medical research methodology 6: 31.
31. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, et al. (2010) Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 102: 1174-1179.
32. Zheng Y, Cui L, Sun W, Zhou H, Yuan X, et al. (2011) MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients. Cancer Biomark 10: 71-77.
33. Li BS, Zhao YL, Guo G, Li W, Zhu ED, et al. (2012) Plasma microRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One 7: e41629.
34. Wang B, Zhang Q, (2012) The expression and clinical significance of circulating microRNA-21 in serum of five solid tumors. J Cancer Res Clin Oncol 138: 1659-1666.
35. Shen J, Feng C, Hao B, Mei L, (2012) Application of miR-21 and let-7a in serum for non-invasive diagnosis of gastric cancer and evaluation of surgery results. Journal of Zhengzhou University(Medical Sciences) 47: 722-725.
36. Edge SB, Compton CC, (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of surgical oncology 17: 1471-1474.
37. Sobin L, Wittekind C (2002) Intenational Union Against Cancer (UICC). TNM Classification of Malignant Tumors 6th edn John Wiley & Sons. Inc: New York.
38. Schmittgen TD, Livak KJ, (2008) Analyzing real-time PCR data by the comparative CT method. Nature protocols 3: 1101-1108.
39. Nobili S, Bruno L, Landini I, Napoli C, Bechi P, et al. (2011) Genomic and genetic alterations influence the progression of gastric cancer. World journal of gastroenterology 17: 290-299.
40. Yamashita K, Sakuramoto S, Watanabe M, (2011) Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications. Surgery today 41: 24-38.
41. Ye T, Chen Y, Fang J, (2010) DNA methylation biomarkers in serum for gastric cancer screening. Mini Reviews in Medicinal Chemistry 10: 1034-1038.
42. Sapari NS, Loh M, Vaithilingam A, Soong R, (2012) Clinical potential of DNA methylation in gastric cancer: a meta-analysis. PLoS One 7: e36275.
43. Shiota S, Matsunari O, Watada M, Yamaoka Y, (2010) Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in east-Asian countries. Future Microbiol 5: 1885-1893.
44. Zhu YB, Ge SH, Zhang LH, Wang XH, Xing XF, et al. (2012) [Clinical value of serum CEA, CA19-9, CA72-4 and CA242 in the diagnosis and prognosis of gastric cancer]. Zhonghua Wei Chang Wai Ke Za Zhi 15: 161-164.
45. Li Y, Yang Y, Lu M, Shen L, (2011) Predictive value of serum CEA, CA19-9 and CA72.4 in early diagnosis of recurrence after radical resection of gastric cancer. Hepato-gastroenterology 58: 2166-2170.
46. Glas AS, Lijmer JG, Prins MH, Bonsel GJ, Bossuyt PMM, (2003) The diagnostic odds ratio: a single indicator of test performance. Journal of Clinical Epidemiology 56: 1129-1135.
47. Jones CM, Athanasiou T, (2005) Summary receiver operating characteristic curve analysis techniques in the evaluation of diagnostic tests. Ann Thorac Surg 79: 16-20.
48. Walter SD, (2002) Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 21: 1237-1256.
49. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer 127: 2893-2917.